Salvatore Privitera Atri Cure, Inc. (ATRC) insider trading activity

Salvatore Privitera is Chief Technical Officer of AtriCure, Inc.. Currently has a direct ownership of 124,765 shares of ATRC, which is worth approximately $4.16 Million. The most recent transaction as insider was on Mar 01, 2025, when has been sold 8,397 shares (Common Stock) at a price of $38.74 per share, resulting in proceeds of $325,299. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K

19.97% 3M change

26.94% 12M change

Total Value Held $4.16 Million

Salvatore Privitera Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2025	SELL Payment of exercise price or tax liability	$325,299 $38.74 p/Share	8,397 Reduced 6.31%	124,765 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	29,165 Added 17.97%	133,162 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$13,680 $19.35 p/Share	707 Added 0.68%	103,997 Common Stock
May 30 2024	BUY Open market or private purchase	$111,250 $22.25 p/Share	5,000 Added 4.62%	103,290 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$266,803 $36.28 p/Share	7,354 Reduced 6.96%	98,290 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	26,427 Added 20.01%	105,644 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$21,227 $38.11 p/Share	557 Added 0.7%	79,217 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$245,046 $38.81 p/Share	6,314 Reduced 7.43%	78,660 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	24,140 Added 22.12%	84,974 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$12,155 $34.73 p/Share	350 Added 0.57%	60,834 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$466,253 $69.59 p/Share	6,700 Reduced 9.97%	60,484 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	14,614 Added 17.87%	67,184 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$8,924 $59.1 p/Share	151 Added 0.29%	52,570 Common Stock
Jul 30 2021	SELL Open market or private sale	$748,680 $85.0 p/Share	8,808 Reduced 14.39%	52,419 Common Stock
Jul 28 2021	SELL Open market or private sale	$660,000 $82.5 p/Share	8,000 Reduced 11.56%	61,227 Common Stock
Jul 20 2021	SELL Open market or private sale	$160,000 $80.0 p/Share	2,000 Reduced 2.81%	69,227 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$7,818 $45.72 p/Share	171 Added 0.24%	71,227 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$584,788 $66.31 p/Share	8,819 Reduced 11.04%	71,056 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	11,429 Added 12.52%	79,875 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$7,080 $38.48 p/Share	184 Added 0.27%	68,446 Common Stock
Dec 17 2020	SELL Open market or private sale	$546,870 $51.33 p/Share	10,654 Reduced 13.5%	68,262 Common Stock
Dec 09 2020	SELL Open market or private sale	$182,685 $47.5 p/Share	3,846 Reduced 4.65%	78,916 Common Stock

Salvatore Privitera

Chief Technical Officer

Mason, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Value

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

Operation

Value

Type

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC

Account